Literature DB >> 3354961

Pharmacokinetics of intravenously and intramuscularly administered ticarcillin and clavulanic acid in foals.

R W Sweeney1, J Beech, R D Simmons.   

Abstract

Serum concentrations of ticarcillin and clavulanic acid were measured in healthy foals (2 to 6 months old) given the drugs in combination by intravenous and intramuscular routes of administration. Five foals were administered 50 mg of ticarcillin/kg of body weight and 1.67 mg of clavulanic acid/kg, IV. Five foals were administered 100 mg of ticarcillin/kg and 3.33 mg of clavulanic acid/kg, IV, and 4 of those 5 were given the same combined dose IM. The elimination half-life of ticarcillin for intravenous administration was 0.83 hour for the low dosage and 0.96 hour for the high dosage. After intramuscular administration, the half-life of elimination was 2.9 hours, with bioavailability of 54.6%. For IV administered clavulanic acid, the elimination half-life was 0.65 hour for the low dosage and 0.74 hour for the high dosage. After intramuscular administration, the elimination half-life was 0.92 hour, and bioavailability was 68.1%. A combined dosage, 50 mg of ticarcillin/kg and 1.67 mg of clavulanic acid/kg, given every 6 hours is recommended.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3354961

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  2 in total

1.  RGD4C peptide mediates anti-p21Ras scFv entry into tumor cells and produces an inhibitory effect on the human colon cancer cell line SW480.

Authors:  Chen-Chen Huang; Fang-Rui Liu; Qiang Feng; Xin-Yan Pan; Shu-Ling Song; Ju-Lun Yang
Journal:  BMC Cancer       Date:  2021-03-25       Impact factor: 4.430

Review 2.  Untangling the KRAS mutated lung cancer subsets and its therapeutic implications.

Authors:  Kulshrestha Ritu; Pawan Kumar; Amit Singh; K Nupur; Sonam Spalgias; Parul Mrigpuri
Journal:  Mol Biomed       Date:  2021-12-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.